{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:30:04Z","timestamp":1794555004402,"version":"4.9.1"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHE 522\/4\\u20131"],"award-info":[{"award-number":["SCHE 522\/4\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 841"],"award-info":[{"award-number":["SFB 841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["B6"],"award-info":[{"award-number":["B6"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.molmet.2021.101238","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T18:25:12Z","timestamp":1618943112000},"page":"101238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":641,"special_numbering":"C","title":["Metabolic-associated fatty liver disease and lipoprotein metabolism"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5647-1034","authenticated-orcid":false,"given":"Joerg","family":"Heeren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Scheja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2021.101238_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-nutr-071714-034338","article-title":"New insights into the regulation of chylomicron production","volume":"35","author":"Dash","year":"2015","journal-title":"Annual Review of Nutrition"},{"issue":"9","key":"10.1016\/j.molmet.2021.101238_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","article-title":"Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance","volume":"22","author":"Choi","year":"2011","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tem.2020.11.005","article-title":"Lipoprotein lipase and its regulators: an unfolding story","volume":"32","author":"Wu","year":"2021","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOL.0000000000000676","article-title":"Regulation of lipoprotein lipase-mediated lipolysis of triglycerides","volume":"31","author":"Basu","year":"2020","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.molmet.2021.101238_bib5","doi-asserted-by":"crossref","first-page":"101146","DOI":"10.1016\/j.molmet.2020.101146","article-title":"Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD)","author":"Vos","year":"2021","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.molmet.2021.101238_bib6","series-title":"Endotext","article-title":"Introduction to lipids and lipoproteins","author":"Feingold","year":"2000"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pathol.2018.09.062","article-title":"Nonfasting versus fasting lipid profile for cardiovascular risk prediction","volume":"51","author":"Langsted","year":"2019","journal-title":"Pathology"},{"issue":"32","key":"10.1016\/j.molmet.2021.101238_bib8","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circulation Research"},{"key":"10.1016\/j.molmet.2021.101238_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-physiol-031620-094944","article-title":"The ABCs of sterol transport","volume":"83","author":"Plummer","year":"2021","journal-title":"Annual Review of Physiology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MOL.0000000000000697","article-title":"Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020","volume":"31","author":"Pavanello","year":"2020","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.molmet.2021.101238_bib12","first-page":"66","article-title":"Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit","volume":"8","author":"Brites","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) Clinical"},{"key":"10.1016\/j.molmet.2021.101238_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: function matters more than concentration!","volume":"159","author":"Nazir","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.molmet.2021.101238_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annual Review of Physiology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2021.101238_bib17","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Molecular Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.molmet.2021.101238_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib20","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040792","article-title":"Roles of ceramides in non-alcoholic fatty liver disease","volume":"10","author":"Hajduch","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tips.2017.04.004","article-title":"Roles of diacylglycerols and ceramides in hepatic insulin resistance","volume":"38","author":"Petersen","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The association between nonalcoholic fatty liver disease and metabolic abnormalities in the United States population","volume":"51","author":"Jinjuvadia","year":"2017","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.28985","article-title":"Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacl.2017.02.001","article-title":"Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: a focus on atherogenic dyslipidemia","volume":"11","author":"Amor","year":"2017","journal-title":"Journal of Clinical Lipidology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmet.2021.101238_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2019.01.029","article-title":"Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps","volume":"282","author":"Santos","year":"2019","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib30","doi-asserted-by":"crossref","first-page":"11691","DOI":"10.1038\/s41598-018-29639-5","article-title":"Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis","volume":"8","author":"Fadaei","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2021.101238_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2018.07.028","article-title":"Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease","volume":"277","author":"van den Berg","year":"2018","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib32","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00193.2019","article-title":"HDL flux is higher in patients with nonalcoholic fatty liver disease","volume":"317","author":"McCullough","year":"2019","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P088997","article-title":"Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol","volume":"60","author":"van den Berg","year":"2019","journal-title":"The Journal of Lipid Research"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib34","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1194\/jlr.P054387","article-title":"Lipoprotein subclass metabolism in nonalcoholic steatohepatitis","volume":"55","author":"Mannisto","year":"2014","journal-title":"The Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib36","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101238_bib37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/liv.13076","article-title":"Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease","volume":"36","author":"Jiang","year":"2016","journal-title":"Liver International"},{"key":"10.1016\/j.molmet.2021.101238_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2017.08.006","article-title":"Nonalcoholic fatty liver disease associated with metabolic syndrome: influence of liver fibrosis stages on characteristics of very low-density lipoproteins","volume":"473","author":"Lucero","year":"2017","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/apt.13216","article-title":"Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States","volume":"42","author":"Jiang","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.molmet.2021.101238_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","article-title":"Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor","volume":"299","author":"Konishi","year":"2020","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/lipd.12244","article-title":"Relationships between very low-density lipoproteins-ceramides, -diacylglycerols, and -triacylglycerols in insulin-resistant men","volume":"55","author":"Mucinski","year":"2020","journal-title":"Lipids"},{"issue":"9","key":"10.1016\/j.molmet.2021.101238_bib42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI6576","article-title":"Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice","volume":"103","author":"Raabe","year":"1999","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1083\/jcb.201603072","article-title":"TANGO1 and Mia2\/cTAGE5 (TALI) cooperate to export bulky pre-chylomicrons\/VLDLs from the endoplasmic reticulum","volume":"213","author":"Santos","year":"2016","journal-title":"The Journal of Cell Biology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-5793(88)80780-4","article-title":"Evidence that during very low density lipoprotein assembly in rat hepatocytes most of the triacylglycerol and phospholipid are packaged with apolipoprotein B in the Golgi complex","volume":"232","author":"Higgins","year":"1988","journal-title":"FEBS Letters"},{"key":"10.1016\/j.molmet.2021.101238_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","article-title":"Hepatic lipid droplet homeostasis and fatty liver disease","volume":"108","author":"Seebacher","year":"2020","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"48","key":"10.1016\/j.molmet.2021.101238_bib47","doi-asserted-by":"crossref","first-page":"48051","DOI":"10.1074\/jbc.M306898200","article-title":"Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER","volume":"278","author":"Gusarova","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/ATVBAHA.113.302728","article-title":"A\u00a0regulator of secretory vesicle size, Kelch-like protein 12, facilitates the secretion of apolipoprotein B100 and very-low-density lipoproteins--brief report","volume":"34","author":"Butkinaree","year":"2014","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmet.2020.10.020","article-title":"Receptor-mediated ER export of lipoproteins controls lipid homeostasis in mice and humans","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib51","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-007-0790-1","article-title":"Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance","volume":"50","author":"Adiels","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"issue":"36","key":"10.1016\/j.molmet.2021.101238_bib53","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the U.S.A."},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOL.0000000000000663","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease","volume":"31","author":"Welty","year":"2020","journal-title":"Current Opinion in Lipidology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib55","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nature Genetics"},{"issue":"24","key":"10.1016\/j.molmet.2021.101238_bib56","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the U.S.A."},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib57","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nature Genetics"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib58","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","article-title":"The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis","volume":"62","author":"Pirola","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib60","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2015.11.036","article-title":"TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD","volume":"64","author":"Musso","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"20","key":"10.1016\/j.molmet.2021.101238_bib61","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","author":"Smagris","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","article-title":"Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD","volume":"67","author":"Luukkonen","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"17","key":"10.1016\/j.molmet.2021.101238_bib63","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1111\/j.1742-4658.2012.08684.x","article-title":"Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells","volume":"279","author":"Wurie","year":"2012","journal-title":"FEBS Journal"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib64","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.22980","article-title":"Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids","volume":"50","author":"Villanueva","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib65","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.30765","article-title":"Hepatocyte deletion of triglyceride-synthesis enzyme acyl CoA: diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice","volume":"70","author":"Gluchowski","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib66","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbalip.2017.04.004","article-title":"Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in HuH7 hepatoma cells","volume":"1862","author":"Ruhanen","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"9 Pt B","key":"10.1016\/j.molmet.2021.101238_bib67","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"16","key":"10.1016\/j.molmet.2021.101238_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127902","article-title":"Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids","volume":"4","author":"Luukkonen","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib69","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nature Genetics"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib70","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in\u00a0vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"43","key":"10.1016\/j.molmet.2021.101238_bib71","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib72","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib73","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOL.0000000000000569","article-title":"Lipoprotein metabolism in liver diseases","volume":"30","author":"Perez-Matos","year":"2019","journal-title":"Current Opinion in Lipidology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101238_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2013.04.001","article-title":"The regulation of ApoB metabolism by insulin","volume":"24","author":"Haas","year":"2013","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib76","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1210\/en.2013-1856","article-title":"FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver","volume":"155","author":"Kim","year":"2014","journal-title":"Endocrinology"},{"issue":"20","key":"10.1016\/j.molmet.2021.101238_bib77","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.4161\/cc.7.20.6882","article-title":"FoxO1 integrates insulin signaling to VLDL production","volume":"7","author":"Kamagate","year":"2008","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib78","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2337\/diabetes.54.6.1676","article-title":"Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes","volume":"54","author":"Allister","year":"2005","journal-title":"Diabetes"},{"issue":"32","key":"10.1016\/j.molmet.2021.101238_bib79","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1021\/bi200711v","article-title":"Insulin silences apolipoprotein B mRNA translation by inducing intracellular traffic into cytoplasmic RNA granules","volume":"50","author":"Karimian Pour","year":"2011","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib80","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/hq1001.096640","article-title":"Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event","volume":"21","author":"Brown","year":"2001","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib81","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2015-3476","article-title":"Impaired insulin suppression of VLDL-triglyceride kinetics in nonalcoholic fatty liver disease","volume":"101","author":"Poulsen","year":"2016","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib83","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1210\/jc.2019-00875","article-title":"Hepatic fatty acid balance and hepatic fat content in humans with severe obesity","volume":"104","author":"Lytle","year":"2019","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib84","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/jhep.2002.32527","article-title":"Apolipoprotein synthesis in nonalcoholic steatohepatitis","volume":"35","author":"Charlton","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.metabol.2015.10.017","article-title":"Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: the Cardiovascular Health Study","volume":"65","author":"Jiang","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2021.101238_bib86","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1194\/jlr.M016931","article-title":"Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy","volume":"52","author":"Caviglia","year":"2011","journal-title":"The Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib87","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1172\/JCI32752","article-title":"Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents","volume":"118","author":"Ota","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2021.101238_bib88","doi-asserted-by":"crossref","first-page":"101169","DOI":"10.1016\/j.molmet.2021.101169","article-title":"A\u00a0guide to understanding endoplasmic reticulum stress in metabolic disorders","volume":"47","author":"Lemmer","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib89","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2017.10.003","article-title":"NRF1 is an ER membrane sensor that is central to cholesterol homeostasis","volume":"171","author":"Widenmaier","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020242","article-title":"Signaling nodes associated with endoplasmic reticulum stress during NAFLD progression","volume":"11","author":"Koo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmet.2021.101238_bib91","doi-asserted-by":"crossref","first-page":"107401","DOI":"10.1016\/j.pharmthera.2019.107401","article-title":"The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease","volume":"203","author":"Song","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib92","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes & Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib93","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0022-2275(20)35348-7","article-title":"Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans","volume":"34","author":"Faix","year":"1993","journal-title":"The Journal of Lipid Research"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib94","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib95","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib96","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"International Journal of Molecular Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib97","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI99009","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"128","author":"Softic","year":"2018","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib98","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib99","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm4074","article-title":"Transcriptional regulation of hepatic lipogenesis","volume":"16","author":"Wang","year":"2015","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.molmet.2021.101238_bib100","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ncomms2537","article-title":"De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health","volume":"4","author":"Eissing","year":"2013","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib101","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/hep.31198","article-title":"Hepatic carbohydrate response element binding protein activation limits nonalcoholic fatty liver disease development in a mouse model for glycogen storage disease type 1a","volume":"72","author":"Lei","year":"2020","journal-title":"Hepatology"},{"issue":"37","key":"10.1016\/j.molmet.2021.101238_bib102","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M204887200","article-title":"Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles","volume":"277","author":"Grefhorst","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib103","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/ATVBAHA.118.311931","article-title":"Critical role of SREBP-1c large-VLDL pathway in environment-induced hypertriglyceridemia of apo AV deficiency","volume":"39","author":"Takanashi","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3945\/ajcn.114.092262","article-title":"Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis","volume":"101","author":"Lee","year":"2015","journal-title":"American Journal of Clinical Nutrition"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm1540","article-title":"Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins","volume":"13","author":"Lam","year":"2007","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib106","doi-asserted-by":"crossref","first-page":"E1479","DOI":"10.1152\/ajpendo.00351.2012","article-title":"Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats","volume":"303","author":"Rojas","year":"2012","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"14","key":"10.1016\/j.molmet.2021.101238_bib107","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1161\/CIRCULATIONAHA.108.793182","article-title":"Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis","volume":"118","author":"Brown","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib108","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cmet.2007.10.014","article-title":"Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis","volume":"6","author":"Miyazaki","year":"2007","journal-title":"Cell Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2021.101238_bib109","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1194\/jlr.M600172-JLR200","article-title":"Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis","volume":"47","author":"Man","year":"2006","journal-title":"The Journal of Lipid Research"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib110","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1194\/jlr.M020156","article-title":"The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2","volume":"53","author":"Qi","year":"2012","journal-title":"The Journal of Lipid Research"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib111","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.cmet.2018.04.004","article-title":"DGAT2 inhibition alters aspects of triglyceride metabolism in rodents but not in non-human primates","volume":"27","author":"McLaren","year":"2018","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbalip.2008.01.001","article-title":"Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice","volume":"1781","author":"Liu","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib114","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00018-011-0857-5","article-title":"Regulation of cholesterol homeostasis","volume":"69","author":"Goedeke","year":"2012","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib115","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib116","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cmet.2017.08.011","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metabolism"},{"issue":"13","key":"10.1016\/j.molmet.2021.101238_bib117","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1073\/pnas.1002588108","article-title":"Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes","volume":"108","author":"Wu","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the U.S.A."},{"issue":"9","key":"10.1016\/j.molmet.2021.101238_bib118","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1194\/jlr.M003335","article-title":"Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice","volume":"51","author":"Wang","year":"2010","journal-title":"The Journal of Lipid Research"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/ATVBAHA.116.308963","article-title":"Prevention of diet-induced metabolic dysregulation, inflammation, and atherosclerosis in ldlr(-\/-) mice by treatment with the ATP-citrate lyase inhibitor bempedoic acid","volume":"37","author":"Samsoondar","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164133","article-title":"The fatty acid synthase inhibitor platensimycin improves insulin resistance without inducing liver steatosis in mice and monkeys","volume":"11","author":"Singh","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib121","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.04.002","article-title":"New\" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis","volume":"1","author":"Chakravarthy","year":"2005","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib122","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","article-title":"GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Alkhouri","year":"2020","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"13","key":"10.1016\/j.molmet.2021.101238_bib123","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1074\/jbc.M008973200","article-title":"Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay","volume":"276","author":"Xu","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib124","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1194\/jlr.M800383-JLR200","article-title":"Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice","volume":"50","author":"Moon","year":"2009","journal-title":"The Journal of Lipid Research"},{"key":"10.1016\/j.molmet.2021.101238_bib125","doi-asserted-by":"crossref","first-page":"101006","DOI":"10.1016\/j.plipres.2019.101006","article-title":"ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: an updated review","volume":"77","author":"Feng","year":"2020","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.molmet.2021.101238_bib126","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib127","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.22774","article-title":"Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice","volume":"49","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Blood","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/ATVBAHA.117.310473","article-title":"APOC3 loss-of-function mutations, remnant cholesterol, low-density lipoprotein cholesterol, and cardiovascular risk: mediation- and meta-analyses of 137 895 individuals","volume":"38","author":"Wulff","year":"2018","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.molmet.2021.101238_bib131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2020.08.017","article-title":"Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease","volume":"311","author":"Silbernagel","year":"2020","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib132","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.ATV.19.3.472","article-title":"Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3","volume":"19","author":"Jong","year":"1999","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib133","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib134","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0000000000000502","article-title":"Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism","volume":"29","author":"Ramms","year":"2018","journal-title":"Current Opinion in Lipidology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101238_bib135","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1194\/jlr.M093740","article-title":"ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance","volume":"60","author":"Ramms","year":"2019","journal-title":"The Journal of Lipid Research"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib136","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib137","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.24571","article-title":"Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance","volume":"54","author":"Lee","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2021.101238_bib138","doi-asserted-by":"crossref","first-page":"1838679","DOI":"10.1155\/2017\/1838679","article-title":"Apolipoprotein CIII overexpression-induced hypertriglyceridemia increases nonalcoholic fatty liver disease in association with inflammation and cell death","volume":"2017","author":"Paiva","year":"2017","journal-title":"Oxidation Medicine Cell Longevity"},{"issue":"9","key":"10.1016\/j.molmet.2021.101238_bib139","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1074\/jbc.M116.765917","article-title":"APOC3 protein is not a predisposing factor for fat-induced nonalcoholic fatty liver disease in mice","volume":"292","author":"Cheng","year":"2017","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib140","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib141","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.24072","article-title":"Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance","volume":"53","author":"Kozlitina","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib142","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1440-1746.2011.07045.x","article-title":"Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease","volume":"27","author":"Hyysalo","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib143","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/oby.20366","article-title":"A\u00a0gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population","volume":"21","author":"Verrijken","year":"2013","journal-title":"Obesity"},{"issue":"5540","key":"10.1016\/j.molmet.2021.101238_bib144","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib145","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2174\/1389450116666150531161138","article-title":"Apolipoprotein A5: extracellular and intracellular roles in triglyceride metabolism","volume":"16","author":"Forte","year":"2015","journal-title":"Current Drug Targets"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib146","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI26712","article-title":"Give me A5 for lipoprotein hydrolysis!","volume":"115","author":"Merkel","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib147","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.108.172866","article-title":"Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in\u00a0vitro lipoprotein lipase activity and receptor binding","volume":"28","author":"Dorfmeister","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib148","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ncpcardio1326","article-title":"APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia","volume":"5","author":"Wang","year":"2008","journal-title":"Nature Clinical Practice Cardiovascular Medicine"},{"issue":"9726","key":"10.1016\/j.molmet.2021.101238_bib149","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1373\/clinchem.2004.040824","article-title":"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins","volume":"51","author":"O'Brien","year":"2005","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib151","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2004.05.003","article-title":"Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5","volume":"319","author":"Fruchart-Najib","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"27","key":"10.1016\/j.molmet.2021.101238_bib152","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"22","key":"10.1016\/j.molmet.2021.101238_bib153","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","author":"Merkel","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"21","key":"10.1016\/j.molmet.2021.101238_bib154","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99470","article-title":"Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms","volume":"3","author":"Trevino-Villarreal","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib155","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi7000533","article-title":"Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family","volume":"46","author":"Nilsson","year":"2007","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib156","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1172\/JCI67398","article-title":"Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans","volume":"123","author":"Gonzales","year":"2013","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib157","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAT.0000000000000251","article-title":"Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers","volume":"47","author":"Feng","year":"2015","journal-title":"Pathology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib158","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gut.2010.222224","article-title":"The role of apolipoprotein A5 in non-alcoholic fatty liver disease","volume":"60","author":"Ress","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib159","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1194\/jlr.M010793","article-title":"Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion","volume":"52","author":"Blade","year":"2011","journal-title":"The Journal of Lipid Research"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2012.09.065","article-title":"Influence of apolipoprotein A-V on hepatocyte lipid droplet formation","volume":"427","author":"Gao","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib161","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1194\/jlr.C700002-JLR200","article-title":"Apolipoprotein A-V association with intracellular lipid droplets","volume":"48","author":"Shu","year":"2007","journal-title":"The Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib162","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbalip.2010.02.004","article-title":"Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation","volume":"1801","author":"Shu","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib163","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.M054080","article-title":"ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content","volume":"56","author":"Camporez","year":"2015","journal-title":"The Journal of Lipid Research"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib164","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.hbpd.2018.04.004","article-title":"Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease","volume":"17","author":"Xu","year":"2018","journal-title":"Hepatobiliary and Pancreatic Diseases International"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2013.12.009","article-title":"Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant","volume":"233","author":"Albers","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib166","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1194\/jlr.M075689","article-title":"ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance","volume":"58","author":"Haller","year":"2017","journal-title":"The Journal of Lipid Research"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib167","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","article-title":"ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase","volume":"6","author":"Chi","year":"2017","journal-title":"Molecular Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib168","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1194\/jlr.M088807","article-title":"On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity","volume":"60","author":"Kovrov","year":"2019","journal-title":"The Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib169","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1038\/s41467-019-11513-1","article-title":"Angptl8 mediates food-driven resetting of hepatic circadian clock in mice","volume":"10","author":"Chen","year":"2019","journal-title":"Nature Communications"},{"issue":"40","key":"10.1016\/j.molmet.2021.101238_bib170","doi-asserted-by":"crossref","first-page":"16109","DOI":"10.1073\/pnas.1315292110","article-title":"Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis","volume":"110","author":"Wang","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the U.S.A."},{"issue":"17","key":"10.1016\/j.molmet.2021.101238_bib171","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138777","article-title":"ANGPTL8 has both endocrine and autocrine effects on substrate utilization","volume":"5","author":"Oldoni","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib172","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","article-title":"Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism","volume":"303","author":"Ren","year":"2012","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib173","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","article-title":"Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels","volume":"424","author":"Zhang","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"48","key":"10.1016\/j.molmet.2021.101238_bib174","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical angiopoietin-like protein that regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the U.S.A."},{"issue":"8","key":"10.1016\/j.molmet.2021.101238_bib175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1194\/jlr.RA120000781","article-title":"Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids","volume":"61","author":"Chen","year":"2020","journal-title":"The Journal of Lipid Research"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib176","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib177","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1194\/jlr.P066183","article-title":"Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism","volume":"57","author":"Minicocci","year":"2016","journal-title":"The Journal of Lipid Research"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib178","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib179","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease","volume":"374","author":"Myocardial Infarction","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrcardio.2016.46","article-title":"Genetics: polymorphisms in ANGPTL4 link triglycerides with CAD","volume":"13","author":"Lim","year":"2016","journal-title":"Nature Reviews Cardiology"},{"issue":"40","key":"10.1016\/j.molmet.2021.101238_bib181","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1093\/eurheartj\/ehaa689","article-title":"Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia","volume":"41","author":"Gaudet","year":"2020","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib182","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/MEG.0b013e32832b77ae","article-title":"Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance","volume":"21","author":"Yilmaz","year":"2009","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib183","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.P039875","article-title":"Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis","volume":"54","author":"Minicocci","year":"2013","journal-title":"The Journal of Lipid Research"},{"issue":"24","key":"10.1016\/j.molmet.2021.101238_bib184","doi-asserted-by":"crossref","first-page":"21344","DOI":"10.1074\/jbc.M213202200","article-title":"Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor","volume":"278","author":"Inaba","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"37","key":"10.1016\/j.molmet.2021.101238_bib185","doi-asserted-by":"crossref","first-page":"11630","DOI":"10.1073\/pnas.1515374112","article-title":"Hepatic ANGPTL3 regulates adipose tissue energy homeostasis","volume":"112","author":"Wang","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the U.S.A."},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib186","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1194\/jlr.M054890","article-title":"ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys","volume":"56","author":"Gusarova","year":"2015","journal-title":"The Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib187","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41598-017-03538-7","article-title":"Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome","volume":"7","author":"Mele","year":"2017","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib188","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0043-102950","article-title":"ANGPTL8 (betatrophin) is expressed in visceral adipose tissue and relates to human hepatic steatosis in two independent clinical collectives","volume":"49","author":"von Loeffelholz","year":"2017","journal-title":"Hormone and Metabolic Research"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170758","article-title":"Relationship of serum betatrophin with nonalcoholic fatty liver in a Chinese population","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2021.101238_bib190","doi-asserted-by":"crossref","first-page":"24013","DOI":"10.1038\/srep24013","article-title":"Association between betatrophin\/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies","volume":"6","author":"Lee","year":"2016","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib191","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00125-018-4579-1","article-title":"Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents","volume":"61","author":"Vatner","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib192","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1210\/en.2016-1894","article-title":"ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice","volume":"158","author":"Gusarova","year":"2017","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib193","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97918","article-title":"Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis","volume":"3","author":"Aryal","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib194","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jhep.2016.01.025","article-title":"Metabolic interplay between white, beige, brown adipocytes and the liver","volume":"64","author":"Scheja","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib195","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.jhepr.2020.100150","article-title":"Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents","volume":"2","author":"Chin","year":"2020","journal-title":"JHEP Report"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib196","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7110378","article-title":"Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease","volume":"7","author":"Pastori","year":"2018","journal-title":"Journal of Clinical Medicine"},{"issue":"8","key":"10.1016\/j.molmet.2021.101238_bib197","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1210\/jc.2007-0187","article-title":"Postprandial lipemia associates with liver fat content","volume":"92","author":"Matikainen","year":"2007","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4746","key":"10.1016\/j.molmet.2021.101238_bib198","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A\u00a0receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.molmet.2021.101238_bib199","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1111\/j.1742-4658.2011.08238.x","article-title":"Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice","volume":"278","author":"Karavia","year":"2011","journal-title":"FEBS Journal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030668","article-title":"LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease","volume":"7","author":"Bieghs","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib201","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI1240","article-title":"Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants","volume":"101","author":"Rohlmann","year":"1998","journal-title":"Journal of Clinical Investigation"},{"issue":"25","key":"10.1016\/j.molmet.2021.101238_bib202","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.RA118.001952","article-title":"Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression","volume":"293","author":"Hamlin","year":"2018","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2021.101238_bib203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2016.04.002","article-title":"Low-density lipoprotein receptor-related protein-1 protects against hepatic insulin resistance and hepatic steatosis","volume":"7","author":"Ding","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmet.2021.101238_bib204","article-title":"Mutation in the distal NPxY motif of LRP1 alleviates dietary cholesterol-induced dyslipidemia and tissue inflammation","author":"Jaeschke","year":"2020","journal-title":"The Journal of Lipid Research"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib205","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1007\/s00125-011-2274-6","article-title":"Altered endocannabinoid signalling after a high-fat diet in Apoe(-\/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance","volume":"54","author":"Bartelt","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2021.101238_bib206","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"Schierwagen","year":"2015","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib207","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145102","article-title":"Genetic dissection of tissue-specific apolipoprotein E function for hypercholesterolemia and diet-induced obesity","volume":"10","author":"Wagner","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib208","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2003.12.011","article-title":"The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice","volume":"40","author":"Mensenkamp","year":"2004","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.molmet.2021.101238_bib209","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12950-019-0211-5","article-title":"Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Ho","year":"2019","journal-title":"Journal of Inflammation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hep.30401","article-title":"Dietary lipids differentially shape nonalcoholic steatohepatitis progression and the transcriptome of kupffer cells and infiltrating macrophages","volume":"70","author":"McGettigan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2021.101238_bib211","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","author":"He","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib212","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5551\/jat.11.200","article-title":"The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor","volume":"11","author":"Takahashi","year":"2004","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib213","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.26126","article-title":"Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor","volume":"57","author":"Jo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2021.101238_bib214","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmet.2017.12.008","article-title":"Hepatic regulation of VLDL receptor by PPARbeta\/delta and FGF21 modulates non-alcoholic fatty liver disease","volume":"8","author":"Zarei","year":"2018","journal-title":"Molecular Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jhepr.2019.10.009","article-title":"Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice","volume":"1","author":"Lebeau","year":"2019","journal-title":"JHEP Report"},{"key":"10.1016\/j.molmet.2021.101238_bib216","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1177\/2047487317724342","article-title":"PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans","volume":"24","author":"Baragetti","year":"2017","journal-title":"European journal of preventive cardiology"},{"key":"10.1016\/j.molmet.2021.101238_bib217","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurheartj\/ehy357","article-title":"PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor","volume":"40","author":"Da Dalt","year":"2019","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib218","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41598-018-22962-x","article-title":"Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans","volume":"8","author":"Verboven","year":"2018","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib219","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/oby.2011.371","article-title":"The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients","volume":"20","author":"Yang","year":"2012","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiological Reviews"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib221","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41430-018-0323-7","article-title":"Determinants of ectopic liver fat in metabolic disease","volume":"73","author":"Bosy-Westphal","year":"2019","journal-title":"European Journal of Clinical Nutrition"},{"issue":"11","key":"10.1016\/j.molmet.2021.101238_bib222","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1210\/jc.2016-2353","article-title":"Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD","volume":"101","author":"Shojaee-Moradie","year":"2016","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib223","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2021.101238_bib224","article-title":"ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPAR\u03b1 activity","author":"Fougerat","year":"2021","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib225","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2021.101238_bib226","doi-asserted-by":"crossref","first-page":"110785","DOI":"10.1016\/j.biopha.2020.110785","article-title":"The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling","volume":"131","author":"Shabalala","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.molmet.2021.101238_bib227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","article-title":"Fibroblast growth factor 21: a versatile regulator of metabolic homeostasis","volume":"38","author":"BonDurant","year":"2018","journal-title":"Annual Review of Nutrition"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib228","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib229","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.metabol.2010.10.003","article-title":"Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis","volume":"60","author":"Zhu","year":"2011","journal-title":"Metabolism"},{"issue":"32","key":"10.1016\/j.molmet.2021.101238_bib230","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1074\/jbc.M803510200","article-title":"Silencing of hepatic fatty acid transporter protein 5 in\u00a0vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia","volume":"283","author":"Doege","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib231","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1055\/s-0030-1267186","article-title":"A\u00a0promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis","volume":"42","author":"Auinger","year":"2010","journal-title":"Hormone and Metabolic Research"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib232","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.30411","article-title":"Thioesterase superfamily member 2 promotes hepatic VLDL secretion by channeling fatty acids into triglyceride biosynthesis","volume":"70","author":"Alves-Bezerra","year":"2019","journal-title":"Hepatology"},{"issue":"38","key":"10.1016\/j.molmet.2021.101238_bib233","doi-asserted-by":"crossref","first-page":"27299","DOI":"10.1074\/jbc.M113.485219","article-title":"Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation","volume":"288","author":"Wendel","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib234","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1194\/jlr.M089300","article-title":"Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2","volume":"60","author":"Irshad","year":"2019","journal-title":"The Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.molmet.2021.101238_bib235","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1096\/fj.11-202853","article-title":"Thioesterase superfamily member 2\/acyl-CoA thioesterase 13 (Them2\/Acot13) regulates hepatic lipid and glucose metabolism","volume":"26","author":"Kang","year":"2012","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib236","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.M500553-JLR200","article-title":"Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity","volume":"47","author":"Vergnes","year":"2006","journal-title":"The Journal of Lipid Research"},{"issue":"22","key":"10.1016\/j.molmet.2021.101238_bib237","doi-asserted-by":"crossref","first-page":"21506","DOI":"10.1074\/jbc.M412989200","article-title":"Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1","volume":"280","author":"Yamazaki","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib238","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2021.101238_bib239","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1194\/jlr.M600213-JLR200","article-title":"Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production","volume":"47","author":"Millar","year":"2006","journal-title":"The Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiological Reviews"},{"issue":"4","key":"10.1016\/j.molmet.2021.101238_bib241","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2018.06.020","article-title":"Lipolysis triggers a systemic insulin response essential for efficient energy replenishment of activated Brown adipose tissue in mice","volume":"28","author":"Heine","year":"2018","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101238_bib242","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.2297","article-title":"Brown adipose tissue activity controls triglyceride clearance","volume":"17","author":"Bartelt","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.molmet.2021.101238_bib243","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/ncomms7356","article-title":"Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development","volume":"6","author":"Berbee","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.molmet.2021.101238_bib244","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1038\/ncomms15010","article-title":"Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport","volume":"8","author":"Bartelt","year":"2017","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib245","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4357","article-title":"Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis","volume":"23","author":"Worthmann","year":"2017","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2021.101238_bib246","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nm.4346","article-title":"Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling","volume":"23","author":"Giles","year":"2017","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib247","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41374-018-0120-x","article-title":"Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis","volume":"99","author":"Poekes","year":"2019","journal-title":"Laboratory Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2021.101238_bib248","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib249","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2036.2011.04723.x","article-title":"Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans","volume":"34","author":"Yilmaz","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib250","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41591-020-1126-7","article-title":"Brown adipose tissue is associated with cardiometabolic health","volume":"27","author":"Becher","year":"2021","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/j.molmet.2021.101238_bib251","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmet.2016.04.029","article-title":"Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans","volume":"23","author":"Chondronikola","year":"2016","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2021.101238_bib252","article-title":"Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation","author":"Fischer","year":"2020","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2021.101238_bib253","doi-asserted-by":"crossref","first-page":"14146","DOI":"10.1038\/ncomms14146","article-title":"Dietary fatty acid metabolism of brown adipose tissue in cold-acclimated men","volume":"8","author":"Blondin","year":"2017","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.molmet.2021.101238_bib254","doi-asserted-by":"crossref","first-page":"E445","DOI":"10.1152\/ajpendo.00579.2010","article-title":"Organ-specific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography","volume":"300","author":"Labbe","year":"2011","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101238_bib255","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1038\/s41598-019-39561-z","article-title":"[(18)F]BODIPY-triglyceride-containing chylomicron-like particles as an imaging agent for brown adipose tissue in\u00a0vivo","volume":"9","author":"Paulus","year":"2019","journal-title":"Scientific Reports"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:20:04Z","timestamp":1778851204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":255,"alternative-id":["S2212877821000831"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101238","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic-associated fatty liver disease and lipoprotein metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101238"}}